Position in LEGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,254,390
-$2,698,455 QoQ
Shares Held
179,900
-34.3% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Derivatives in LEGN
reported options exposure · as of Mar 31, 2024CallValue
$796,478
CallShares
14,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,076,655 across 360 Biotechnology names. LEGN ranks #53 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in LEGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,254,390 | 179,900 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,952,845 | 273,820 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,643,757 | 81,072 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $6,804,532 | 191,731 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $7,955,226 | 234,460 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $4,118,619 | 126,571 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $7,813,854 | 160,350 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $8,681,415 | 196,013 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $796,478 | 14,200 | Call | Sole | 2026-03-24 | |
| 2024-03-31 | $11,582,977 | 206,507 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $11,274,955 | 187,385 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $18,881,083 | 281,094 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $5,780,365 | 83,737 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $10,779,002 | 223,538 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $49,920 | 1,000 | Put | Sole | 2026-03-30 | |
| 2022-12-31 | $1,497,600 | 30,000 | Call | Sole | 2026-03-30 | |
| 2022-12-31 | $23,574,919 | 472,254 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $12,289,449 | 301,212 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $16,110,160 | 292,912 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,915,145 | 245,326 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||